“Hypothesis of Seven Balances”: Molecular Mechanisms behind Alcoholic Liver Diseases and Association with PPARα

“Hypothesis of Seven Balances”: Molecular Mechanisms behind Alcoholic Liver Diseases and Association with PPARα: Takashi Moriya, et al. Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine

[1]  Michael Müller,et al.  Peroxisome Proliferator-Activated Receptor Alpha Target Genes , 2010, PPAR research.

[2]  X. D. Wang.  Chronic alcohol intake interferes with retinoid metabolism and signaling. , 2009, Nutrition reviews.

[3]  C. Lieber,et al.  An experimental model of alcohol feeding and liver injury in the baboon. , 2009, Journal of medical primatology.

[4]  M. Pinzani,et al.  Reversal of Liver Fibrosis , 2009, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[5]  A. Baker.  Alcohol-related deaths by occupation: what do data for England and Wales in 2001-2005 tell us about doctors' mortality? , 2008, Alcohol and alcoholism.

[6]  H. Tsukamoto,et al.  Fat paradox of steatohepatitis , 2008, Journal of gastroenterology and hepatology.

[7]  Jordi Muntané,et al.  Mecanismos de lesión hepatocelular , 2007 .

[8]  K. Wolski,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[9]  S. Nissen,et al.  Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. , 2007, JAMA.

[10]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[11]  N. Müller,et al.  Sustained JNK Activation in Response to Tumor Necrosis Factor Is Mediated by Caspases in a Cell Type-specific Manner* , 2007, Journal of Biological Chemistry.

[12]  S. Friedman,et al.  Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference , 2007, Hepatology.

[13]  S. Friedman.  Transcriptional regulation of stellate cell activation , 2006, Journal of gastroenterology and hepatology.

[14]  T. Luedde,et al.  Evaluation of the role of nuclear factor‐κB signaling in liver injury using genetic animal models , 2006, Journal of gastroenterology and hepatology.

[15]  Q. Zhai,et al.  Alcohol‐induced oxidative stress and cell responses , 2006, Journal of gastroenterology and hepatology.

[16]  A. Cederbaum.  Cytochrome P450 2E1‐dependent oxidant stress and upregulation of anti‐oxidant defense in liver cells , 2006, Journal of gastroenterology and hepatology.

[17]  P. Park,et al.  Regulation of Kupffer cell activity during chronic ethanol exposure: Role of adiponectin , 2006, Journal of gastroenterology and hepatology.

[18]  David A. Brenner,et al.  Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways , 2006 .

[19]  T. Noda,et al.  Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways* , 2006, Journal of Biological Chemistry.

[20]  M. Kamijima,et al.  A review of hazardous chemical toxicity studies utilizing genetically-modified animals--their applications for risk assessment. , 2005, Industrial health.

[21]  F. Oakley,et al.  The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis , 2005, Apoptosis.

[22]  W. Bensch,et al.  Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression , 2005, Molecular Pharmacology.

[23]  D. Crabb,et al.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice , 2005, Hepatology.

[24]  J. Auwerx,et al.  PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse , 2005, Respiratory research.

[25]  F. Anania,et al.  The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. , 2005, The American journal of pathology.

[26]  Y. Matsuzawa.  Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. , 2005, Atherosclerosis. Supplements.

[27]  A. Ganesan,et al.  Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity , 2005, Apoptosis.

[28]  T. Kadowaki.  [Recent advances in PPARs research--basic and clinical aspects]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[29]  H. Fujii.  [Anti-inflammatory action of PPARs]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[30]  J. Doyle,et al.  Metabolic syndrome and robustness tradeoffs. , 2004, Diabetes.

[31]  Yuichi Harano,et al.  PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats , 2004 .

[32]  J. Peters,et al.  Peroxisome proliferator‐activated receptor α protects against alcohol‐induced liver damage , 2004 .

[33]  J. Peters,et al.  Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. , 2004, Hepatology.

[34]  C. McClain,et al.  Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[35]  L. Romics,et al.  Diverse regulation of NF‐κB and peroxisome proliferator‐activated receptors in murine nonalcoholic fatty liver , 2004, Hepatology.

[36]  C. Lieber,et al.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. , 2004, Alcohol.

[37]  M. Wheeler,et al.  Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[38]  P. Froguel,et al.  Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity* , 2004, Journal of Biological Chemistry.

[39]  M. Czaja.  Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine , 2004, Hepatology.

[40]  D. Crabb,et al.  Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[41]  H. Yoshimatsu,et al.  Adiponectin protects LPS‐induced liver injury through modulation of TNF‐α in KK‐Ay obese mice , 2004 .

[42]  R. Rao,et al.  Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[43]  S. Kersten,et al.  Peroxisome proliferator-activated receptor α target genes , 2004, Cellular and Molecular Life Sciences CMLS.

[44]  S. Kihara,et al.  Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. , 2003, Gastroenterology.

[45]  S. Kihara,et al.  Obesity, adiponectin and vascular inflammatory disease , 2003, Current opinion in lipidology.

[46]  S. Zolotukhin,et al.  Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Groszmann,et al.  I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. , 2003, Alcoholism, clinical and experimental research.

[48]  R. Groszmann,et al.  II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. , 2003, Alcoholism, clinical and experimental research.

[49]  L. Nagy.  Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease , 2003, Experimental biology and medicine.

[50]  D. Brenner,et al.  Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. , 2003, Journal of hepatology.

[51]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[52]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[53]  C. McClain,et al.  Prevention of Alterations in Intestinal Permeability Is Involved in Zinc Inhibition of Acute Ethanol-Induced Liver Damage in Mice , 2003, Journal of Pharmacology and Experimental Therapeutics.

[54]  G. Gores,et al.  Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic , 2003, Laboratory Investigation.

[55]  P. Whittaker,et al.  PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effect , 2003 .

[56]  G. Su,et al.  Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[57]  G. Su,et al.  Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[58]  M. Salaspuro,et al.  Microbes and mucosa in the regulation of intracolonic acetaldehyde concentration during ethanol challenge. , 2002, Alcohol and alcoholism.

[59]  R. Gamelli,et al.  Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[60]  G. Arteel,et al.  Role of Lipopolysaccharide-Binding Protein in Early Alcohol-Induced Liver Injury in Mice1 , 2002, The Journal of Immunology.

[61]  I. Rusyn,et al.  The role of Kupffer cell oxidant production in early ethanol-induced liver disease. , 2001, Free radical biology & medicine.

[62]  G. Su,et al.  Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[63]  A. Keshavarzian,et al.  Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. , 2001, The Journal of pharmacology and experimental therapeutics.

[64]  I. Rusyn,et al.  Alcohol‐induced free radicals in mice: Direct toxicants or signaling molecules? , 2001, Hepatology.

[65]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[66]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[67]  R. Rao,et al.  Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[68]  I. Rusyn,et al.  Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. , 2001, Gastroenterology.

[69]  R. McCuskey,et al.  Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. , 2001, Alcoholism, clinical and experimental research.

[70]  D. Crabb,et al.  The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. , 2001, The Journal of biological chemistry.

[71]  D. Crabb,et al.  The Transcriptional and DNA Binding Activity of Peroxisome Proliferator-activated Receptor α Is Inhibited by Ethanol Metabolism , 2001, The Journal of Biological Chemistry.

[72]  Y. Liaw,et al.  Constitutive activation of nuclear factor κB in hepatocellular carcinoma , 2000 .

[73]  B. Staels,et al.  Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators* , 2000, The Journal of Biological Chemistry.

[74]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[75]  A. Keshavarzian,et al.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats , 2000, Hepatology.

[76]  M. Manns,et al.  Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure , 2000 .

[77]  B. Ahluwalia,et al.  Alcohol modulates cytokine secretion and synthesis in human fetus: an in vivo and in vitro study. , 2000, Alcohol.

[78]  Sander Kersten,et al.  Roles of PPARs in health and disease , 2000, Nature.

[79]  C. Bode,et al.  Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. , 2000, Journal of hepatology.

[80]  G. Gores,et al.  Apoptosis and liver disease. , 2000, The American journal of medicine.

[81]  K. Hoppo,et al.  Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. , 2000, Alcoholism, clinical and experimental research.

[82]  I. Rusyn,et al.  Gender differences in early alcohol-induced liver injury: role of CD14, NF-κB, and TNF-α , 2000 .

[83]  Y. Liaw,et al.  Activation of nuclear factor κB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis , 2000, Hepatology.

[84]  S. Friedman.  Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[85]  F. Piscaglia,et al.  Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. , 1999, Gastroenterology.

[86]  M. Luster,et al.  Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice , 1999 .

[87]  P. Libby,et al.  PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells , 1999 .

[88]  J. Rodés,et al.  S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. , 1999, Journal of hepatology.

[89]  C. Lieber,et al.  Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. , 1998, Alcoholism, clinical and experimental research.

[90]  M. Singer,et al.  Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. , 1998, Alcohol and alcoholism.

[91]  R. Thurman,et al.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. , 1998, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[92]  S. Gordon,et al.  Recognizing death: the phagocytosis of apoptotic cells. , 1998, Trends in cell biology.

[93]  W. Koenig,et al.  Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.

[94]  R. Batey,et al.  Decreased Tumor Necrosis Factor‐α and Interleukin‐1α Production from Intrahepatic Mononuclear Cells in Chronic Ethanol Consumption and Upregulation by Endotoxin , 1998 .

[95]  M. Luster,et al.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat , 1997, Hepatology.

[96]  M. Salaspuro,et al.  Microbial metabolism of ethanol and acetaldehyde and clinical consequences , 1997, Addiction biology.

[97]  M. Salaspuro.  Bacteriocolonic pathway for ethanol oxidation: characteristics and implications. , 1996, Annals of medicine.

[98]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[99]  D. Bunout,et al.  Effects of long-term vitamin E supplementation in alcoholic cirrhotics. , 1995, Journal of the American College of Nutrition.

[100]  Y. Wan,et al.  Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. , 1994, Life sciences.

[101]  A. Keshavarzian,et al.  The differing effects of acute and chronic alcohol on gastric and intestinal permeability. , 1994, The American journal of gastroenterology.

[102]  A. Nanji,et al.  Lactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease) , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[103]  N. Sheron,et al.  Circulating and tissue levels of the neutrophil chemotaxin interleukin‐8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration , 1993, Hepatology.

[104]  A. Nanji,et al.  Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. , 1993, The American journal of pathology.

[105]  A. Rosman,et al.  Induction of cytochrome P‐4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA , 1993, Hepatology.

[106]  C. Lieber.  Alcoholic liver injury , 1992 .

[107]  C. McClain,et al.  Increased plasma interleukin-6 concentrations in alcoholic hepatitis. , 1992, The Journal of laboratory and clinical medicine.

[108]  C. McClain.  Tumor necrosis and alcoholic hepatitis Bird GLA, Sheron N, Goka AKJ, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917–920 , 1991 .

[109]  C. Bode,et al.  Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. , 1991, Journal of hepatology.

[110]  F. Fiaccadori,et al.  Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. , 1990, Gastroenterology.

[111]  G. Alexander,et al.  Increased plasma tumor necrosis factor in severe alcoholic hepatitis. , 1990, Annals of internal medicine.

[112]  R. Veech,et al.  Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. , 1990, Alcoholism, clinical and experimental research.

[113]  A. Rosman,et al.  The intralobular distribution of ethanol‐inducible P450IIE1 in rat and human liver , 1989, Hepatology.

[114]  T. Miller,et al.  Effects of ethanol and prostaglandin on rat gastric mucosal tight junctions. , 1987, The Journal of surgical research.

[115]  C. McClain,et al.  Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. , 1986, Life sciences.

[116]  H. Tsukamoto,et al.  Ethanol‐induced liver fibrosis in rats fed high fat diet , 1986, Hepatology.

[117]  C. Lieber,et al.  Quantitative relationship between amount of dietary fat and severity of alcoholic fatty liver. , 1970, The American journal of clinical nutrition.

[118]  T. Tephly,et al.  Alcohol Metabolism: Role of Microsomal Oxidation in vivo , 1969, Science.

[119]  M. K. Roach,et al.  Ethanol oxidation in the microsomal fraction of rat liver. , 1969, Biochemical and biophysical research communications.

[120]  C. Lieber,et al.  Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. , 1967, The Journal of clinical investigation.

[121]  C. Lieber,et al.  EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS. , 1965, The Journal of clinical investigation.

[122]  R. Schwabe,et al.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[123]  C. J. Marek,et al.  Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. , 2005, Gastroenterology.

[124]  D. Grobbee,et al.  Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. , 2004, Diabetes care.

[125]  M. Haluzík,et al.  Adiponectin and its role in the obesity-induced insulin resistance and related complications. , 2004, Physiological research.

[126]  D. Crabb,et al.  Recent Advances in Alcoholic Liver Disease , 2004 .

[127]  David R Ragland,et al.  Burnout and alcohol problems among urban transit operators in San Francisco. , 2003, Addictive behaviors.

[128]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[129]  T. Awata,et al.  The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells , 2001 .

[130]  H. Flynn.  Comparison of cross-sectional and daily reports in studying the relationship between depression and use of alcohol in response to stress in college students. , 2000, Alcoholism, clinical and experimental research.

[131]  A. Keshavarzian,et al.  Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage , 1999, American Journal of Gastroenterology.

[132]  R. Thurman.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. , 1998, American Journal of Physiology.

[133]  R. Thurman,et al.  Antibiotics prevent liver injury in rats following long-term exposure to ethanol. , 1995, Gastroenterology.

[134]  C. Lieber.  Medical and Nutritional Complications of Alcoholism , 1992, Springer US.